Acknowledgement
I need to mention the efforts of our dear colleagues, Mr. Mohammad Reza Javanshir and Reza Naghdi who helped us, build the seed source.
References
- Kim JH, Hilaris B. Iodine 125 source in interstitial tumor therapy. Clinical and biological considerations. Am J Roentgenol Radium Ther Nucl Med. 1975;123(1):163-169. https://doi.org/10.2214/ajr.123.1.163
- Shahzadi S, Azimi P, Parsa K. Long-term results of stereotactic brachytherapy (temporary 125iodine seeds) for the treatment of low-grade astrocytoma (grade II). Iran Red Crescent Med J. 2013;15(1):49-57. https://doi.org/10.5812/ircmj.4322
- Ghassemi F, Sheibani S, Arjmand M, Poorbaygi H, Kouhestani E, Sabour S, et al. Comparison of iodide-125 and ruthenium-106 brachytherapy in the treatment of choroidal melanomas. Clin Ophthalmol. 2020;14:339-346. https://doi.org/10.2147/OPTH.S235265
- Cattani F, Vavassori A, Polo A, Rondi E, Cambria R, Orecchia R, et al. Radiation exposure after permanent prostate brachytherapy. Radiother Oncol. 2006;79(1):65-69. https://doi.org/10.1016/j.radonc.2006.02.010
- Anglesio S, Calamia E, Fiandra C, Giglioli FR, Ragona R, Ricardi U, et al. Prostate brachytherapy with iodine-125 seeds: radiation protection issues. Tumori. 2005;91(4):335-338. https://doi.org/10.1177/030089160509100410
- Kaulich TW, Lamprecht U, Paulsen F, Lorenz J, Maurer U, Loeser W, et al. Physikalisch-technische Qualitatssicherung und Strahlenschutz bei der Monotherapie der Prostata mit Jod-125-Seeds [Physical and technical quality assurance and radiation protection in transperineal interstitial permanent prostate brachytherapy with 125-iodine seeds]. Strahlenther Onkol. 2002;178(12):667-675 (German). https://doi.org/10.1007/s00066-002-0997-5
- Fujii K, Ko S, Nako Y, Tonari A, Nishizawa K, Akahane K, et al. Dose measurement for medical staff with glass dosemeters and thermoluminescence dosemeters during 125I brachytherapy for prostate cancer. Radiat Prot Dosimetry. 2011;144(1-4):459-463. https://doi.org/10.1093/rpd/ncq572
- Schiefer H, von Toggenburg F, Seelentag W, Plasswilm L, Ries G, Lenggenhager C, et al. Exposure of treating physician to radiation during prostate brachytherapy using iodine-125 seeds: dose measurements on both hands with thermoluminescence dosimeters. Strahlenther Onkol. 2009;185(10):689-695. https://doi.org/10.1007/s00066-009-1990-z
- Al-Haj AN, Lobriguito AM, Lagarde CS. Radiation dose profile in 125I brachytherapy: an 8-year review. Radiat Prot Dosimetry. 2004;111(1):115-119. https://doi.org/10.1093/rpd/nch372
- Classic KL, Furutani KM, Stafford SL, Pulido JS. Radiation dose to the surgeon during plaque brachytherapy. Retina. 2012;32(9):1900-1905. https://doi.org/10.1097/IAE.0b013e3182509827
- Souza DCB, Rostelato MEC, Vicente R, Zeituni CA, Tiezzi R, Costa OL, et al. Assessment of the risks associated with iodine-125 handling production sources for brachytherapy. 2015 International Nuclear Atlantic Conference (INAC); 2015 Oct 4-9; Sao Paulo, Brazil. Available from: https://inis.iaea.org/collection/NCLCollectionStore/_Public/47/035/47035623.pdf
- International Atomic Energy Agency. Implications for occupational radiation protection of the new dose limit for the lens of the eye: IAEA-TECDOC, no. 1731 [Internet]. IAEA; 2013 [cited 2023 Dec 12]. Available from: https://www-pub.iaea.org/MTCD/Publications/PDF/TE-1731_web.pdf
- Bahruddin NA, Hashim S, Karim MKA, Sabarudin A, Ang WC, Salehhon N, et al. Radiation dose to physicians' eye lens during interventional radiology. J Phys Conf Ser. 2016;694:012035.
- Netherlands Commission on Radiation Dosimetry. Guidelines for radiation protection and dosimetry of the eye lens [Internet]. Netherlands Commission on Radiation Dosimetry; 2018 [cited 2023 Dec 12]. Available from: https://doi.org/10.25030/ncs-031
- International Organization of Standardization. ISO 15382: Radiological protection: procedures for monitoring the dose to the lens of the eye, the skin and the extremities. ISO; 2015.
- International Radiation Protection Association. IRPA guidance on implementation of eye dose monitoring and eye protection of workers [Internet]. IRPA; 2017 [cited 2023 Dec 12]. Available from: https://www.irpa.net/docs/IRPA%20Guidance%20on%20Implementation%20of%20Eye%20Dose%20Monitoring%20(2017).pdf
- Wang B, Xu XG, Bozkurt A, Goorley JT. Issues related to the use of MCNP code for an extremely large voxel model VIP-Man. American Nuclear Society Topical Mitting in Monte Carlo; 2005 Apr 17-21; Chattanooga, TN, USA.
- Lohrabian V, Sheibani S, Aghamiri MR, Ghozati B, Poorbaygi H, Baghani HR. Determination of dosimetric characteristics of IrSeed 125I brachytherapy source. Iran J Med Phys. 2013;10(2):109-117.
- Sheikholeslami S, Nedaie HA, Sadeghi M, Pourbeigy H, Shahzadi S, Zehtabian M, et al. Monte Carlo calculations and experimental measurements of the TG-43U1-recommended dosimetric parameters of 125I (Model IR-Seed2) brachytherapy source. J Appl Clin Med Phys. 2016;17(4):430-441. https://doi.org/10.1120/jacmp.v17i4.6127
- Carrillo RE, Uribe RM, Woodruff GL, Stoebe TG. Lithium fluoride (TLD-700) response to a mixed thermal neutron and gamma field. Radiat Prot Dosimetry. 1987;19(1):55-57.
- Meigooni AS, Mishra V, Panth H, Williamson J. Instrumentation and dosimeter-size artifacts in quantitative thermoluminescence dosimetry of low-dose fields. Med Phys. 1995;22(5):555-561. https://doi.org/10.1118/1.597555
- Xu XG. An exponential growth of computational phantom research in radiation protection, imaging, and radiotherapy: a review of the fifty-year history. Phys Med Biol. 2014;59(18):R233-R302. https://doi.org/10.1088/0031-9155/59/18/R233
- James MR, McKinney GW, Durkee JW, Fensin ML, Hendricks JS, Pelowitz DB, et al. MCNPX 2.7.X: New features being developed LA-UR-09-6788. 2009 IEEE/NSS Conference; 2009 Oct 25-31; Orlando, FL, USA. p. 25-31.
- Martin CJ, Magee JS, Sandblom V, Almen A, Lundh C. Eye dosimetry and protective eyewear for interventional clinicians. Radiat Prot Dosimetry. 2015;165(1-4):284-288. https://doi.org/10.1093/rpd/ncv050